Additionally, the same antibody has shown effective inhibition of viral infection and the cytokine storm caused by SARS-CoV-2 and its variants26, which combined with the encouraging clinical trial results, further illustrating the promise of treating COVID-19 by targeting CD147. The gene discussed is BSG; the disease is COVID-19.